Infectious disease outbreaks will continue to increase and trying to find strategies to ensure providers are cared for to prevent burnout and shortage staffing is essential if another pandemic arises.
Maryann Webb’s harrowing, personal experience with C diff, along with her professional work with federal agencies has prepared her for a life in advocacy with the Peggy Lillis Foundation. She wants to see the fecal microbiota transplant become more accessible and is working with Congress to make the infection a notifiable infectious disease.
Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.
Epidemiologic and clinical lessons for the uninitiated.
To close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.
Read more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.
Here is a review the mechanisms that lead to resistance, including risk factors.
New data demonstrates protection against new variants.
New therapeutics offer some hope in this emerging market.
Jennifer Ronholm, PhD, discusses the novel concept of microbiome protection to create healthier animals and reduce antimicrobial usage.
Inequities can include access to care issues that run from prevention to acute treatment. Addressing such issues can lead to better outcomes.
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.
A study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.
In this case study, clinicians review a challenging case.
The 340B program has had a great impact on access to HIV treatment and prevention services in the US.
The key is using the right dose on the right patient at the right time.
Jeanine Thomas, president and founder of MRSA Survivors Network, talks about her personal battle with osteomyelitis, her work as an advocate, and the need for data and awareness to bring it to the forefront again.
This unusual Case Study describes a young woman who presented with an acute onset of headaches and dizziness and was found to have aseptic meningitis.
Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Here is a case study involving a patient with the virus and the clinical approach in thinking about appropriate treatment while keeping stewardship in mind.
Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.
Amanda Jezek, of the Infectious Diseases Society of America (IDSA), offers some insight on the prospective bill in Congress, as well as other AMR initiatives the organization is involved in.
The first 2024 case of tularemia also known as rabbit fever was confirmed in a Wheat Ridge, Colorado resident.
Read more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.
An assessment of a comparative study between leading options for a burdensome infection.
In the latest article from SIDP, here is a look at the use of various intravenous (IV) antimicrobial therapies to address infections in these patients.
At 7.1%, vitamin C deficiency in the US is rare. Unfortunately, identifying scurvy is complex, frustrating, and time-consuming for both patient and provider.